Want to see ELV full AI Analyst Report?
ELV Stock Chart & Stats
$323.05
<$0.01(<0.01%)
At close: 4:00 PM EST
$323.05
<$0.01(<0.01%)
Day’s Range― - ―
52-Week Range$273.71 - $427.64
Previous CloseN/A
Volume477.50K
Average Volume (3M)1.69M
Market Cap
$91.29B
Enterprise Value$107.15B
Total Cash (Recent Filing)$35.56B
Total Debt (Recent Filing)$31.84B
Price to Earnings (P/E)17.8
Beta0.40
Next Earnings
Jul 15, 2026EPS Estimate
6.21Next Dividend Ex-DateN/A
Dividend Yield1.99%
Share Statistics
EPS (TTM)23.51
Shares Outstanding217,162,380
10 Day Avg. Volume1,495,889
30 Day Avg. Volume1,693,018
Financial Highlights & Ratios
PEG Ratio-5.70
Price to Book (P/B)1.77
Price to Sales (P/S)0.39
P/FCF Ratio24.50
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue0.53
Enterprise Value/Gross Profit2.31
Enterprise Value/Ebitda12.02
Forecast
1Y Price Target
$424.74Price Target Upside31.48% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19
EPS Forecast (FY)26.91
Revenue Forecast (FY)$194.96B
Bulls Say, Bears Say
Bulls Say
Scale & Membership GrowthLarge, diversified membership across commercial, Medicare and Medicaid supports durable revenue scale and underwriting diversification. Steady membership and multi-year revenue growth create cost leverage, broader negotiating power with providers, and resilient premium inflows over a multi-quarter horizon.
Improved Cash GenerationA meaningful TTM free cash flow rebound and stronger operating cash flow underpin capital allocation flexibility. Consistent FCF coverage of earnings allows funding for buybacks, investments in Carelon/AI and potential regulatory payments while preserving liquidity across the next several quarters.
Carelon Clinical & Product TractionMeasured clinical outcomes and post-acute savings validate Carelon's integrated care model and support scalable third-party revenue. Demonstrable readmission and cost improvements strengthen competitive differentiation and position the services business to capture durable demand for value-based care.
Bears Say
CMS Risk-adjustment Accrual & Regulatory TimelineA sizable accrual and looming CMS compliance deadlines create regulatory and timing uncertainty that can materially affect cash flows and enrollment operations. Potential sanctions, remediation costs and ongoing oversight raise execution risk and could limit Medicare Advantage growth flexibility.
Medicaid Margin & Membership PressureSustained Medicaid membership declines and a negative operating margin expectation imply structural headwinds from eligibility reverifications and reimbursement dynamics. Persistent negative Medicaid profitability can weigh on consolidated margins and require cross-subsidization or pricing adjustments.
Balance-sheet Data InconsistencyAn unexplained sharp shift in reported total debt undermines transparency around leverage and liquidity. Even with equity growth and moderate leverage historically, such data discontinuities complicate capital planning and risk assessment for multi-quarter stress scenarios or large regulatory cash outflows.
Elevance Health News
ELV FAQ
What was Elevance Health, Inc.’s price range in the past 12 months?
Elevance Health, Inc. lowest stock price was $273.71 and its highest was $427.64 in the past 12 months.
What is Elevance Health, Inc.’s market cap?
Elevance Health, Inc.’s market cap is $91.29B.
When is Elevance Health, Inc.’s upcoming earnings report date?
Elevance Health, Inc.’s upcoming earnings report date is Jul 15, 2026 which is in 3 days.
How were Elevance Health, Inc.’s earnings last quarter?
Elevance Health, Inc. released its earnings results on Apr 22, 2026. The company reported $12.58 earnings per share for the quarter, beating the consensus estimate of $10.819 by $1.761.
Is Elevance Health, Inc. overvalued?
According to Wall Street analysts Elevance Health, Inc.’s price is currently Undervalued.
Does Elevance Health, Inc. pay dividends?
Elevance Health, Inc. pays a Quarterly dividend of $1.72 which represents an annual dividend yield of 1.99%. See more information on Elevance Health, Inc. dividends here
What is Elevance Health, Inc.’s EPS estimate?
Elevance Health, Inc.’s EPS estimate is 6.21.
How many shares outstanding does Elevance Health, Inc. have?
Elevance Health, Inc. has 217,162,380 shares outstanding.
What happened to Elevance Health, Inc.’s price movement after its last earnings report?
Elevance Health, Inc. reported an EPS of $12.58 in its last earnings report, beating expectations of $10.819. Following the earnings report the stock price went up 0.027%.
Which hedge fund is a major shareholder of Elevance Health, Inc.?
Currently, no hedge funds are holding shares in ELV
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Elevance Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$424.74 (31.48% Upside)
$424.74 (31.48% Upside)
Blogger Sentiment
Bullish
ELV Sentiment 70%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 264.4K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $826.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.8%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
22.87%
12-Months-Change
Fundamentals
Return on Equity
11.95%
Trailing 12-Months
Asset Growth
5.10%
Trailing 12-Months
Company Description
Elevance Health, Inc.
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
ELV Company Deck
ELV Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call emphasized strong execution and tangible operational improvements that drove a Q1 EPS beat, an upgraded full-year EPS guide, share repurchases and growing demand for integrated clinical and pharmacy offerings. Management also highlighted meaningful AI investments and measurable clinical results from Carelon/CareBridge (20% readmission reduction, >10% post-acute savings). Offsetting these positives are a material $935 million accrual related to a CMS historical risk-adjustment matter, a $129 million optimization charge, ongoing elevated Medicaid cost trends and some margin pressure and investment-driven cadence at Carelon. On balance the positives (guidance raise, underlying business beats, membership growth, cash generation and scalable AI/Carelon proof points) outweigh the negatives (one-time accrual, Medicaid pressure, Carelon margin timing), supporting a constructive outlook with manageable risks.View all ELV earnings summariesELV Stock 12 Month Forecast
Average Price Target
$424.74
▲(31.48% Upside)
Technical Analysis
Ownership Overview
0.17% Insiders
27.36% Mutual Funds
0.47% Other Institutional Investors
47.20% Public Companies and Individual Investors